Trial intelligence / Profile preview

Suboxone: Comparison of Two Taper Schedules

NCT00078117Phase 3Completed

Sponsor
University of California, Los Angeles
Start
Jun 2003
Primary completion
May 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of Suboxone in opioid use disorder (OUD) (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Opiate abstinence. Started Jun 2003; status: completed.

02

Drugs

Suboxone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00078117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00078117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call